Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Serologicals Charts. Click Here for more Serologicals Charts.](/p.php?pid=staticchart&s=N%5ESERO&p=8&t=15)
Serologicals Corporation (NASDAQ:SERO) announced today
that it will release its fourth quarter earnings on Wednesday,
February 22, 2006 after the close of regular trading hours, and then
host a conference call on Thursday, February 23, 2006 at 9:00 a.m.
(ET) to review the results.
The conference call dial in number is 866-700-7477, International
dial-in 617-213-8840, confirmation code 16643853. The live broadcast
will also be available online at the Company's website at
www.serologicals.com and at www.StreetEvents.com.
If you are unable to participate in the call, a 14-day playback
will start February 23, 2006 at 11:00 a.m. (Eastern Time). To listen
to the playback, please call 888-286-8010, International dial-in
617-801-6888, and enter access code 71392296, or access the archived
web cast on the Company's website at www.serologicals.com.
Serologicals Corporation (NASDAQ:SERO), headquartered in Atlanta,
GA., is a global leader in developing and commercializing consumable
biological products, enabling technologies and services in support of
biological research, drug discovery, and the bioprocessing of
life-enhancing products. Our customers include researchers at major
life science companies and leading research institutions involved in
key disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and stem
cell research. In addition, Serologicals is the world's leading
provider of monoclonal antibodies for the blood typing industry.
Serologicals employs a total of more than 1,000 people worldwide in
three Serologicals' companies: Chemicon International, headquartered
in Temecula, CA, Upstate Group, LLC, headquartered in Charlottesville,
VA. and Celliance Corporation, headquartered in Atlanta, GA.
Serologicals is a registered trademark of Serologicals Investment
Company.